From: Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study
β
p
OR (95% CI)
Taking antimalarials when relapsed or at the end of follow-up
− 3.584
0.033
0.028 (0.001, 0.743)